| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $486.8M | +53.9% |
| R&D Expense | $34.3M | +53.6% |
| SG&A Expense | $161.7M | +30.4% |
| Operating Income | $47.0M | +233.1% |
| Interest Expense | $32.5M | +14.3% |
| Pre-tax Income | $19.9M | +131.7% |
| Income Tax | $1.1M | +107.4% |
| Net Income | $18.8M | +139.2% |
| EPS (Basic) | $0.86 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $221.1M | +358.5% |
| Accounts Receivable | $162.1M | -2.0% |
| Inventory | $111.2M | +5.5% |
| Current Assets | $519.8M | +51.0% |
| Total Assets | $904.4M | +19.0% |
| Current Liabilities | $145.5M | +46.3% |
| Long-term Debt | $284.8M | -0.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $119.0M | +481.2% |
| Capital Expenditures | $8.9M | -0.1% |
| Investing Cash Flow | -$18.5M | -17.6% |
| Financing Cash Flow | $67.4M | +1415.6% |
| Free Cash Flow | $110.1M | +374.7% |
| +128.2% |
| EPS (Diluted) | $0.85 | +127.9% |
| Total Liabilities |
| $446.8M |
| +6.0% |
| Stockholders' Equity | $432.7M | +38.0% |